MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience DPO Ratio 2011-2026 | HBIO
Annual DPO Ratio Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.4 | 39.5 | 38.8 | 49.5 | 37.6 | 46.6 | 36.3 | 40.3 | 53.5 | 38.7 | 29.7 | 29.1 | 30.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.5 | 29.1 | 39.8 |
Quarterly DPO Ratio Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.7 | 48.8 | 45.6 | - | 54.5 | 54.3 | 54.3 | - | 47.1 | 40.4 | 48.8 | - | - | 22.6 | 40.3 | - | 44.8 | 49.4 | 48.9 | - | 51.7 | 57.6 | 47.8 | 35.5 | 39.2 | 35.8 | 48.1 | 44.4 | 52.4 | 41.5 | 39.8 | 37.9 | 43.7 | 40.7 | 56.9 | 39.5 | 42.5 | 39.1 | 48.8 | 51.9 | 57.2 | 49.5 | 48.1 | 34.8 | 41 | 39.1 | 34.1 | 27 | 31.5 | 31.1 | 30.9 | 28.8 | 30.2 | 28.7 | 29.4 | 28.6 | 31.2 | 15.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 57.6 | 15.8 | 41.6 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
59.3 | $ 184.86 | 1.31 % | $ 53.2 B | USA |
 |
Baxter International
BAX
|
45.6 | $ 21.74 | 1.85 % | $ 11.2 B | USA |
 |
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
73.7 | $ 11.29 | -8.21 % | $ 228 M | USA |
 |
ICU Medical
ICUI
|
39.2 | $ 155.85 | 4.08 % | $ 3.84 B | USA |
 |
Alcon
ALC
|
63.6 | $ 82.21 | -1.21 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
68.7 | $ 32.79 | 1.27 % | $ 1.57 B | USA |
 |
electroCore
ECOR
|
279 | $ 6.16 | -0.16 % | $ 34 K | USA |
 |
LeMaitre Vascular
LMAT
|
14.5 | $ 92.55 | 0.75 % | $ 2.08 B | USA |
 |
AngioDynamics
ANGO
|
96.2 | $ 11.22 | 0.13 % | $ 458 M | USA |
 |
InfuSystem Holdings
INFU
|
62.5 | $ 7.9 | - | $ 163 M | USA |
 |
The Cooper Companies
COO
|
72.6 | $ 84.11 | 0.51 % | $ 16.7 B | USA |
 |
Haemonetics Corporation
HAE
|
41.9 | $ 61.61 | 1.55 % | $ 3.1 B | USA |
 |
iRhythm Technologies
IRTC
|
7.87 | $ 150.56 | -5.24 % | $ 4.82 B | USA |
 |
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
67.2 | $ 119.69 | 2.21 % | $ 5.8 B | USA |
 |
Repro Med Systems
KRMD
|
52 | $ 4.72 | 0.64 % | $ 215 M | USA |
 |
OraSure Technologies
OSUR
|
36.6 | $ 2.76 | -2.47 % | $ 205 M | USA |
 |
Masimo Corporation
MASI
|
84.4 | $ 175.38 | 0.03 % | $ 9.35 B | USA |
 |
Intuitive Surgical
ISRG
|
23.9 | $ 504.2 | 0.93 % | $ 180 B | USA |
 |
Merit Medical Systems
MMSI
|
34.4 | $ 82.25 | 0.5 % | $ 4.79 B | USA |
 |
Microbot Medical
MBOT
|
52.9 | $ 2.07 | -3.95 % | $ 21.1 M |  Israel |
 |
Nephros
NEPH
|
50.5 | $ 4.14 | 6.43 % | $ 43 M | USA |
 |
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | USA |
 |
Milestone Scientific
MLSS
|
36.5 | $ 0.26 | -2.04 % | $ 20.7 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
54.3 | $ 12.63 | 0.88 % | $ 2.57 B | USA |
 |
Envista Holdings Corporation
NVST
|
54.2 | $ 29.16 | 1.53 % | $ 4.9 B | USA |
 |
Pro-Dex
PDEX
|
35.4 | $ 39.55 | 1.41 % | $ 130 M | USA |
 |
Pulse Biosciences
PLSE
|
1.51 K | $ 21.98 | -12.38 % | $ 1.48 B | USA |
 |
Predictive Oncology
POAI
|
547 | - | - | $ 31.1 M | USA |
 |
Stereotaxis
STXS
|
99 | $ 2.08 | -0.24 % | $ 168 M | USA |
 |
Repligen Corporation
RGEN
|
24.3 | $ 136.76 | -0.34 % | $ 7.62 M | USA |
 |
ResMed
RMD
|
34.9 | $ 258.04 | 0.68 % | $ 37.7 B | USA |
 |
BioLife Solutions
BLFS
|
130 | $ 23.17 | -0.26 % | $ 1.07 B | USA |
 |
STERIS plc
STE
|
31.8 | $ 250.32 | -0.34 % | $ 24.7 B | USA |
 |
Retractable Technologies
RVP
|
48.6 | $ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
STAAR Surgical Company
STAA
|
74.3 | $ 17.65 | -1.29 % | $ 867 M | USA |
 |
Teleflex Incorporated
TFX
|
37.1 | $ 115.88 | 3.65 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
18 | $ 67.96 | 2.09 % | $ 247 M | USA |
 |
West Pharmaceutical Services
WST
|
45.7 | $ 241.54 | -0.94 % | $ 17.5 B | USA |